← Eichor
Condition: Proteinuria Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Proteinuria

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
Phase N/A · 5 location(s) · University of Michigan · NCT01016613A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor
Phase 3 · 179 location(s) · Bayer · NCT05457283Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children
Phase 3 · 1 location(s) · Children's Hospital of Fudan University · NCT06890143Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051Empagliflozin Treatment in Kidney Transplant Recipients
Phase 4 · 5 location(s) · VA Office of Research and Development · NCT06013865ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Phase N/A · 1 location(s) · Christoph Aufricht · NCT06162546A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Sev
Phase 2 · 1 location(s) · SynAct Pharma Aps · NCT04456816ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Phase 4 · 1 location(s) · Ace Cells Lab Limited · NCT07187713Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Phase 3 · 87 location(s) · Novartis Pharmaceuticals · NCT04817618Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · 131 location(s) · Novartis Pharmaceuticals · NCT05755386A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Phase 2 · 23 location(s) · Akebia Therapeutics · NCT07268638A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidne
NA · 2 location(s) · St. James's Hospital, Ireland · NCT07561957Kidney Health: Eat Well, Live Well
NA · 3 location(s) · University of Texas at Austin · NCT05970341A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, a
Phase 3 · 164 location(s) · Bayer · NCT05196035The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Phase 2 · 1 location(s) · University of North Carolina, Chapel Hill · NCT06059664Proteinuria in Pre and Post Transplant
Phase N/A · 1 location(s) · University of Miami · NCT01094327Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Part
Phase 2 · 15 location(s) · AstraZeneca · NCT06942910Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)
Phase N/A · 1 location(s) · University of Manitoba · NCT02818192Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
Phase N/A · 1 location(s) · King's College London · NCT07260071Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Phase 2 · 103 location(s) · Novartis Pharmaceuticals · NCT05268289Effects of Exogenous Ketosis on Proteinuria and Renal Function
NA · 1 location(s) · Gødstrup Hospital · NCT06867471A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Phase 2 · 9 location(s) · Jade Biosciences, Inc. · NCT07541287An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomeruloscleros
Phase 2 · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06664814The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06528405Role of Vitamin K2 in Chronic Kidney Disease
Phase 4 · 1 location(s) · Tanta University · NCT05942053Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Dise
Phase 4 · 1 location(s) · Centenario Hospital Miguel Hidalgo · NCT07405216Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Phase 4 · 1 location(s) · Capital Institute of Pediatrics, China · NCT07315191The International PNH Interest Group PNH Registry
Phase N/A · 1 location(s) · International PNH Interest Group · NCT06524726
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.